194
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

In vitro evaluation of the nematicidal effect of Duddingtonia flagrans silver nanoparticles against strongylid larvae (L3)

, , , , , , , ORCID Icon, & show all
Pages 905-909 | Received 19 Sep 2021, Accepted 29 Nov 2021, Published online: 19 Dec 2021
 

ABSTRACT

Recently, the production process of a nanoparticle with nematicidal activity from a nematophagous fungus was developed. Thus, a new strategy to control parasites has been discovered. The aim of the present study was to evaluate the in vitro activity of silver nanoparticles (AgNP’s) biosynthesized from Duddingtonia flagrans filtrate on the control of strongylid larvae of ruminants. This is the first report of a nematicidal activity of AgNP’s – D. flagrans on bovine strongylids, which can be an important biotechnological tool for the use of nanoparticles produced from D. flagrans.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

All the financial support throughout the group’s research was provided by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), FAPES (Fundação de Amparo à Pesquisa e Inovação do Espírito Santo) and FAPEMIG (Fundação de Amparo à Pesquisa de Minas Gerais).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.